{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:48:55Z","timestamp":1786135735773,"version":"build-2736575974"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1681\/asn.2022040461","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T10:55:17Z","timestamp":1657882517000},"page":"1625-1625","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["On the Importance of Considering Glycosylation When Evaluating Biologic Therapies"],"prefix":"10.1681","volume":"33","author":[{"given":"Mathieu","family":"Lemaire","sequence":"first","affiliation":[{"name":"Program in Cell Biology, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada"},{"name":"Division of Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Department of Pediatrics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,8]]},"reference":[{"key":"B1-20250823","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1681\/ASN.2021040561","article-title":"Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial","volume":"32","author":"Ravani","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B2-20250823","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.1073\/pnas.0914634107","article-title":"Colloquium paper: Uniquely Human Evolution of Sialic Acid Genetics and Biology","volume":"107","author":"Varki","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B3-20250823","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nbt.1651","article-title":"Implications of the Presence of N-Glycolylneuraminic Acid in Recombinant Therapeutic Glycoproteins","volume":"28","author":"Ghaderi","year":"2010","journal-title":"Nat Biotechnol"},{"key":"B4-20250823","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5661\/bger-28-147","article-title":"Production Platforms for Biotherapeutic Glycoproteins. Occurrence, Impact, and Challenges of Non-Human Sialylation","volume":"28","author":"Ghaderi","year":"2012","journal-title":"Biotechnol Genet Eng Rev"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2022040461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:48:47Z","timestamp":1786132127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.2022040461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2022040461","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}